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Abstract: The American Heart Association (AHA) has advocated that women and men not 
consume more than 100 and 150 kcal/day, respectively, from added sugars. These levels 
are currently exceeded by over 90% of the adult population in the United States. Few data 
exist on longer-term metabolic effects when sucrose and High Fructose Corn Syrup 
(HFCS), the principal sources of added dietary sugars, are consumed at levels typical of the 
general population. Sixty five overweight and obese individuals were placed on a eucaloric 
(weight stable) diet for 10-weeks, which incorporated sucrose- or HFCS-sweetened,  
low-fat milk at 10% or 20% of calories in a randomized, double-blinded study. All groups 
responded similarly (interaction p > 0.05). There was no change in body weight in any of 
the groups over the 10-week study, or in systolic or diastolic blood pressure. Likewise, 
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there were no changes in total cholesterol, triglycerides, low-density lipoprotein (LDL), or 
apolipoprotein B (Apo B). We conclude that (1) when consumed as part of a eucaloric diet 
fructose—when given with glucose (as normally consumed) does not promote weight gain 
or an atherogenic lipid profile even when consumed at two to four times the level recently 
recommended by the AHA. (2) There were no differences between HFCS and sucrose on 
these parameters. 
Keywords: sucrose; high fructose corn syrup; body mass 
 
1. Introduction 
The prevalence of overweight and obesity have increased significantly over the last 30 years in the 
United States [1–3]. Furthermore, numerous studies have shown that obesity correlates with 
established risk factors for coronary heart disease (CHD) [4,5]. In this time period consumption of 
several macronutrients including added fats, flour/cereals and added sugars have increased [6–8]. 
Some recent reports have suggested a potential association between intake of sugars and adverse 
effects on cardiovascular health [9]. In particular, some evidence in humans suggests that increased 
intake of sugars may raise blood pressure [10–12], although the data are inconsistent [13]. Other 
studies suggest that increased sugars may raise triglyceride levels and lower high-density lipoprotein 
(HDL) cholesterol [14–16], although once again, the data are inconsistent [17,18]. Studies relating 
increased consumption of sugar to low-density lipoprotein (LDL) and LDL particle size are also 
inconsistent [19,20]. Some [21,22], but not all [23,24], studies have also linked higher consumption of 
added sugar to increased oxidative stress and inflammation. Some epidemiologic studies have 
suggested a relationship between added sugar consumption and increased risk of obesity [25–27]. 
Other studies have disputed these findings [28,29]. Several recent studies have shown an association 
between sugar sweetened beverage consumption and increased risk of obesity in children as well as in 
adults who are genetically predisposed to obesity [30–32]. 
The American Heart Association (AHA) has recently issued a Scientific Statement suggesting that 
individuals limit added sugars to no more than half of their discretionary caloric allowance; that is, no 
more than 150 and 100 cal/day for most American men and women, respectively [9]. The AHA 
statement acknowledges that these recommendations are based on limited data and that relatively few 
randomized, prospective trials have been conducted. Many of the studies suggesting links between 
added sugars and cardiovascular disease are either epidemiologic, which establish associations rather 
than cause and effect [27,28], or experiments comparing pure fructose versus pure glucose at 
exaggerated levels, a model system that does not reflect the way that sugars are consumed in the 
normal human diet [33–35]. Very few studies have explored the effects of sucrose or High Fructose 
Corn Syrup (HFCS), the major added sugars in the U.S., at normal population consumption levels [36]. 
It has been argued that the fructose moiety of both sucrose and HFCS may be particularly 
worrisome due to its effects on body weight and cardiovascular risk factors [37–39]. Both sucrose and 
HFCS are comprised of roughly 50% glucose and 50% fructose. Sucrose is half fructose/half glucose, 
while the two major forms of HFCS in common use, HFCS-42 and HFCS-55, are comprised of 42% 
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fructose/53% glucose/5% glucose oligomers and 55% fructose/42% glucose/3% glucose oligomers, 
respectively [8]. 
While consumption of HFCS increased significantly in the U.S. between 1970 and 1999 largely at 
the expense of the sucrose it replaced, its use has been in steady decline for the past decade [40].  
It should be noted that fructose and added sugars from all sources have declined in the United States 
since 1999 [41,42]. At present, the middle 50% of the American adult population for consumption of 
total fructose represents an intake of 10% of total calories which corresponds to 20% of total calories 
from added sugars. However, more sucrose is still consumed in the U.S. each year than HFCS, and 
worldwide, nine times as much sucrose is used than HFCS [8]. 
It has been postulated that differences in metabolism between glucose and fructose may be a 
contributing factor to weight gain and obesity, and increased risk of cardiovascular disease and various 
metabolic conditions such as the metabolic syndrome and diabetes [25–28]. It has also been postulated 
that consumption of fructose from any source, whether it be sucrose or HFCS or any of the other 
glucose/fructose containing nutritive sweeteners, may independently contribute to hypertension, 
dyslipidemias and insulin resistance [38,39–43]. 
With this information as background, the current study was undertaken to explore whether two 
different amounts of sucrose or HFCS consumed at levels equal to the 25th and 50th percentile of the 
US adult population consumption level for total fructose have any adverse impact on body weight or 
body composition and blood lipids or blood pressure in a free living, longitudinal study lasting  
10-weeks. Overweight and obese individuals were chosen since they are most at risk for these 
metabolic abnormalities. To our knowledge, this is the first prospective study to examine the effects of 
added sugars on overweight/obese individuals when sugars are consumed at levels typical of the  
adult population. 
2. Experimental Section 
2.1. Study Design 
This study was a 10-week, randomized, prospective, double blinded trial involving 
overweight/obese subjects between the ages of 25 and 60. The consequences were compared of 
consuming sucrose or HFCS at 10% or 20% of total calories (25th or 50th percentile population intake 
levels of fructose) as a component of the usual diet in a free living environment. The study was 
approved by the Western Institutional Review Board (Project identification code: 20091302, date of 
approval: 27 July 2009) and the University of Central Florida Institutional Review Board and all 
participants signed uniformed consent documents. 
2.2. Subjects 
Men and women between the ages of 25 and 60 years of age with Body Mass Index (BMI)  
27.0–35.0 kg/m2 were recruited. Exclusions included current enrollment in any commercial weight 
loss program, prescription medicines or supplements for weight loss, or a greater than five pound 
change in weight during the past three months. Individuals with a history of orthopedic limitations that 
would interfere with the ability to meet prescribed exercise, a history of heart problems, a history of 
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major surgery within the last three months, clinically diagnosed eating disorders or any gastrointestinal 
disorder, dietary restrictions or allergies to any component of the diet or which would limit the ability 
to adhere to dietary requirements of the study were all excluded. Users of tobacco products or 
individuals consuming more than 14 alcoholic beverages per week were also excluded. 
Interested individuals were initially screened over the phone to determine eligibility based on  
self-reported data. Those who were eligible participated in a clinical screening visit to verify a 
qualifying height and weight, to rule out undiagnosed hypertension, and to obtain a fasting blood 
sample for the measurement of glucose, insulin, lipids and C Reactive protein (CRP). Individuals who 
failed to meet study inclusion criteria were dismissed at that time. 
Each subject performed a second screening visit one week later. During this visit, research dietitians 
assessed participant dietary intake by analyzing a completed three day food record using Nutrient Data 
System Research (NDS-R) Software (University of Minnesota, Minneapolis, MN, USA). Body 
composition was determined by Dual X-Ray Absorptiometry (General Electric i-DXA, Madison, WI, 
USA). All females were required to have a negative serum pregnancy test prior to DXA testing. Repeat 
measurements were performed after the end of 10 weeks. All cholesterol samples were sent to a 
certified research-based laboratory with error rates of less than 1%. 
2.3. Intervention 
Throughout the 10-week intervention participants were required to incorporate an amount of low-fat 
(1% fat) flavored milk sweetened with either HFCS or sucrose (nutritional composition is provided in 
Table 1), according to their randomly assigned group:  
GROUP #1 (HFCS 10%): 10% of recommended calories provided from HFCS in the milk 
(equivalent to the 25th percentile for intake of fructose for adults). 
GROUP #2 (HFCS 20%): 20% of recommended calories provided from HFCS in the milk  
(50th percentile for intake of fructose for adults). 
GROUP #3 (Suc 10%): 10% of recommended calories from sucrose in the milk (25th percentile 
intake of fructose for adults). 
GROUP #4 (Suc 20%): 20% of recommended calories from sucrose in the milk (50th percentile 
intake of fructose). 
2.4. Nutritional Plans 
Participants were provided a structured eating plan based on the American Diabetes Association 
(ADA) exchange lists. Overall caloric level was determined using the Mifflin-St. Jeor calculation for 
Resting Energy Expenditure (REE) with activity factor included based on responses to a physical 
activity questionnaire. Daily consumption levels of the test beverage were then calculated according 
the group assignment (10% or 20% calories from added sugar). Increases in added sugar from the milk 
were accounted for by reductions in the number of other carbohydrate exchanges allowed.  
As indicated in Table 1, each carton of milk contained either 11 grams of HFCS or sucrose or 22 g of 
HFCS or sucrose. The milk was prepared by mixing either HFCS or sucrose solids into a standard  
1% milk solution. The amount of solids added were dependent on whether the milk was intended for 
those at the 10% consumption level (11 g of solids per 240 mL of milk) or the 20% consumption level 
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(22 g of solids per 240 mL of milk). There was no fructose or glucose added to the milk so the only 
that was present were those in the lactose moiety or the added HFCS or sucrose solids. 
Individuals in the 10% HFCS or sucrose groups were given milk containing the lower amount of 
HFCS or sucrose, while individuals in the 20% HFCS or sucrose groups were given milk containing 
the higher amount of HFCS or sucrose containing milk. Then, based on the calculated caloric needs of 
each participant, they were assigned a number of cartons that provided them with either 10% or 20% 
of their estimated caloric needs from the sweeteners. This could have been as few as two cartons or 
many as five or six cartons. 
Table 1. Nutrient composition of milk. 
Formulation 1% Fat Milk and Carbohydrate 
Ingredient 
1% Low Fat 
Milk 
HFCS or 
Sucrose 
Solids 
HFCS or 
Sucrose Solids
Consumption Level  10% 20% 
Dose 240 mL 11 g 22 g 
Fat (g) 2.5 0 0 
Carbohydrate (g) 13 11 22 
Protein (g) 8 0 0 
Calories    
From Milk 110   
From Added Sweetener  44 88 
Total Per Serving 110 154 198 
HFCS: High Fructose Corn Syrup. 
Both participants and investigators were blinded to the type of sugar given to each participant. 
However, while participants were also blinded to whether they were in a 10% or 20% sugar group, 
investigators were aware of this information since it was necessary to prescribe the right number of 
other carbohydrate exchanges. Compliance with diet and test beverage was checked weekly based on 
completed checklists turned in during a visit in which participants would also have their weight 
measured and be supplied with another weeks supply of test beverage. Participants were withdrawn if 
they failed to consume the prescribed milk for five consecutive days or if they failed to maintain an 
overall level of consumption of at least 80% of that prescribed. All sweeteners were supplied in 1%, 
low-fat milk (Tetra Pak, Denton, TX, USA) as described above. 
2.5. Data Analysis 
Data were checked for normalcy and analyzed using a two way (time and group assignment) 
Analysis of Variance with repeated measures. Significant time X group assignment interactions were 
probed by assessing the within subject change within each of the 4 groups separately. In addition, 
changes over the course of 10-weeks (week 10-baseline) were calculated and among group differences 
assessed by one way Analysis of variance (ANOVA). For all analyses the alpha value was set at 0.05. 
All data were analyzed using SPSS Advanced Statistics V18 (SPSS® Statistics is a comprehensive 
system for analyzing data, (IBM, Armonk, NY, USA). 
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3. Results 
3.1. Compliance and Participant Attrition 
Of the 86 individuals who started the study, 65 completed the 10-week intervention. Reasons for 
attrition were varied and included unwillingness to maintain milk consumption levels, inability to 
attend clinical appointments and investigator determined exclusion due to non-compliance. Only data 
from the 65 participants who completed the study are presented herein. Baseline characteristics are 
shown in Table 2. Compliance with prescribed milk intake was very high with over 96% of 
recommended servings being consumed. Milk consumption among finishers was ranged from two to 
six eight ounce cups/day in order to achieve either 10% or 20% of calories from HFCS or sucrose. 
3.2. Dietary Intake 
Despite the addition of the sugar-sweetened milk, participants followed a structured dietary plan 
designed to provide a weight-maintenance level of calories. However, as shown in Table 3, according 
to analysis of 3 day food diaries caloric intake increased (p < 0.001), irrespective of group assignment 
(interaction p = 0.925). There were also increases in carbohydrate and protein and total sugar intake 
(all p < 0.001). Of these, only sugar intake was affected by group assignment (interaction < 0.01). 
While there was a trend towards a larger increase in consumption for both total and added sugar in the 
20% groups compared to the 10% groups statistical significance was only reached for the comparisons 
between HFCS 20% and sucrose 10% for total sugar, and HFCS 20% vs. both 10% groups for added 
sugar. No changes were observed in intake of dietary fat (p > 0.05). 
3.3. Body Composition 
Changes in body mass and measures of adiposity and body composition are presented in Table 4. 
While there were no significant changes in body weight for any individual group, a slight increase in 
body weight was observed when assessing the entire cohort (mean = 2.2 ± 4.9 lbs, p < 0.01).  
While this was statistically significant, during the screening of prospective participants being “weight 
stable” was defined as there being no change in weight greater than 5 lbs during the past 30 days. Such 
a change in weight as observed in the present study would therefore still be classified as being 
“weight-stable” according the criteria used for screening participants. This observed increase in weight 
represented an increase in percent body fat and fat mass (p < 0.01 for both). Importantly changes in 
these measures were comparable across the 4 groups suggesting group assignment did not influence 
the degree of weight or fat gain. 
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Table 2. Baseline participant characteristics. 
Participants 
All 
(n = 65, M = 34,  
F = 31) 
HFCS 10% 
(n = 17, M= 9,  
F= 8) 
HFCS 20% 
(n = 17, M = 8,  
F = 9) 
Sucrose 10% 
(n = 18, M = 12,  
F = 6) 
Sucrose 20% 
(n = 13, M = 5,  
F = 8) 
Mean ± S.D Mean ± S.D Mean ± S.D Mean ± S.D Mean ± S.D 
Age (years) 39.12 ± 11.76 39.82 ± 11.60 39.33 ± 10.94 41.15 ± 12.24 36.48 ± 12.50 
Gender (%)      
Female 52 53 47 67 38 
Male 48 47 53 33 62 
Race (%) Caucasian = 68 Caucasian = 71 Caucasian = 68 Caucasian = 72 Caucasian = 69 
 
African American = 9 
Hispanic = 14 
Asian = 6 
Other = 3 
African American = 12 
Hispanic = 12 
Other = 6 
African American = 12
Hispanic = 18 
Asian = 12 
African American = 11
Hispanic = 6 
Asian = 11 
African American = 23 
Other = 8 
Height (inches) 66.37 ± 3.77 66.71 ± 4.79 66.30 ± 3.66 66.74 ± 4.05 65.37 ± 3.71 
Body Weight (lbs) 179.55 ± 36.12 180.66 ± 40.98 180.31 ± 38.36 178.30 178.87 ± 33.37 
BMI 28.58 ± 4.31 27.79 ± 4.30 29.43 ± 3.51 27.96 ± 3.97 29.30 ± 3.88 
Waist Circumference (cm) 89.51 ± 11.71 89.16 ± 12.63 91.04 ± 12.75 88.67 ± 11.64 89.18 ± 10.39 
Body Fat % 36.31 ± 8.19 36.12 ± 7.74 38.63 ±7.51 32.75 ± 8.91 37.79 ± 7.90 
Systolic Blood Pressure (mmHg) 112.46 ± 13.53 111.36 ± 12.81 112.10 ± 14.21 116.00 ± 16.58 110.76 ± 10.81 
Diastolic Blood Pressure (mmHg) 73.60 ± 11.55 70.50 ± 15.61 73.48 ± 10.87 75.15 ± 10.99 75.35 ± 7.50 
Cholesterol (mg/dL) 183.60 ± 36.61 196.77 ± 39.53 178.24 ± 30.99 175.00 ± 38.25 183.39 ± 34.42 
Triglycerides (mg/dL) 128.60 ± 73.61 122.05 ± 57.34 126.48 ± 69.99 121.05 ± 67.09 143.39 ± 95.55 
High Density Lipoprotein (mg/dL) 51.13 ± 14.36 53.09 ± 13.40 48.24 ± 15.63 52.70 ± 15.81 50.57 ± 29.64 
Low Density Lipoprotein (mg/dL) 106.95 ± 32.19 118.64 ± 37.71 104.67 ± 23.76 98.10 ± 34.68 105.56 ± 29.64 
M: male; F: female. 
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Table 3. Changes in macronutrient profile of the diet after ten weeks of sugar sweetened 
milk consumption as part of a eucaloric diet. 
Variable Time HFCS 10% HFCS 20% Suc 10% Suc 20% All 
Energy Intake Baseline 2204 ± 1076 2115 ± 477 2542 ± 1407 2086 ± 964 2260 ± 1048 
(kcal) Week 10 2588 ± 758 2546 ± 836 2970 ± 1786 2328 ± 686 2644 ± 1160 *** 
Interaction p = 0.925  
Carbohydrate Baseline 273.6 ± 125.1 255.9 ± 62.6 323.4 ± 178.2 236.6 ± 102.3 277.2 ± 129.2 
(g) Week 10 341.6 ± 97.5 374.3 ± 132.2 383.0 ± 242.2 348.6 ± 102.0 363.4 ± 158.8 *** 
Interaction p = 0.389  
Fat Baseline 83.5 ± 57.2 82.2 ± 26.5 94.9 ± 58.5 90.8 ± 53.7 87.7 ± 49.8 
(g) Week 10 86.2 ± 38.2 72.2 ± 30.7 99.4 ± 66.9 62.2 ± 23.4 82.3 ± 46.4 
Interaction p = 0.074  
Protein Baseline 89.6 ± 28.2 91.8 ± 22.7 99.7 ± 59.7 85.9 ± 39.2 92.5 ± 40.1 
(g) Week 10 122.0 ± 31.9 109.1 ± 33.8 144.2 ± 69.5 108.0 ± 29.7 122.7 ± 47.6 *** 
Interaction p = 0.165  
Total Sugar Baseline 126.4 ± 65.9 110.6 ± 43.2 154.4 ± 121.0 108.9 ± 69.2 127.5 ± 82.6 
(g) Week 10 199.6 ± 56.1 *** 247.9 ± 99.5 *** 218.8 ± 144.6 ** 215.4 ± 83.6 *** 220.5 ± 102.7 *** 
Interaction p < 0.05  
Note: ** Different within group than baseline, p < 0.01; *** different within group than baseline, p < 0.001. 
Table 4. Changes in body mass, body composition and waist circumference after ten 
weeks of sugar sweetened milk consumption as part of a eucaloric diet. 
Variable  Time HFCS 10% HFCS 20% Suc 10% Suc 20% All 
Body Mass Baseline 185.4 ± 44.3 184.5 ± 35.3 179.3 ± 34.4 182.2 ± 39.9 182.8 ± 37.7 
(lbs) Week 10 186.2 ± 43.9 187.9 ± 36.0 181.4 ± 33.9 184.4 ± 41.1 185.0 ± 37.9 **
Interaction p = 0.507 
Waist Baseline 90.4 ± 13.5 90.9 ± 14.0 88.6 ± 11.2 90.2 ± 11.6 90.0 ± 12.4 
(cm) Week10 90.2 ± 13.2 91.8 ± 14.2 89.5 ± 11.1 90.6 ± 12.1 90.5 ± 12.4 
Interaction p = 0.678 
Body Fat Baseline 35.6 ± 7.3 38.7 ± 7.2 32.6 ± 9.2 37.7 ± 4.8 36.0 ± 7.7 
(%) Week 10 35.8 ± 7.3 38.8 ± 7.0 33.8 ± 9.1 38.1 ± 5.0 36.5 ± 7.5 ** 
Interaction p = 0.075 
Fat Mass Baseline 64.2 ±23.5 68.0 ± 15.5 57.3 ± 23.0 66.4 ± 16.2 63.7 ± 20.1 
(lbs) Week 10 64.8 ± 23.0 69.5 ± 15.9 59.7 ± 22.6 68.2 ± 17.7 65.3 ± 20.1 ** 
Interaction p = 0.532 
Fat Free Mass Baseline 120.3 ± 27.0 115.3 ± 28.5 121.7 ± 21.7 114.3 ± 26.3 118.1 ± 26.0 
(lbs) Week 10 120.9 ± 29.3 116.9 = 28.1 120.8 ± 22.0 117.3 ± 27.9 118.6 ± 26.3 
Interaction p = 0.080 
Note: ** different within group than baseline, p < 0.01. 
3.4. Blood Pressure and Blood Lipids 
No changes in systolic (114.12 ± 12.71 vs. 113.92 ± 11.52 mmHg, p > 0.05) or diastolic blood 
pressure (73.91 ± 12.01 vs. 75.38 ± 9.11 mmHg, p > 0.05) were observed, and these parameters were 
unaffected by the treatment group (interactions p = 0.792 and p = 0.666, respectively). 
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Blood lipid data are presented in Table 5. In summary, sweetened milk consumption was seen to 
result in an overall decrease in HDL (p < 0.01) and increase in total cholesterol to HDL  
ratio (p < 0.01), which were unaffected by treatment group (interaction p > 0.05). However, changes in 
total cholesterol, LDL and Apo B were different among the groups—change in HFCS 20% was more 
positive than that observed in Sucrose 20% However, this was largely driven by an unexpected 
decrease in this group for these three measures. Triglycerides were unchanged after the  
10-weeks (p > 0.05). 
Table 5. Changes in blood lipids after ten weeks of sugar sweetened milk consumption as 
part of a eucaloric diet. 
Variable Time HFCS 10% HFCS 20% Suc 10% Suc 20% All 
Total Baseline 198.3 ± 31.4 178.9 ± 27.5 173.5 ± 35.5 194.2 ± 29.7 185.8 ± 32.3 
Cholesterol Week 10 192.2 ± 30.4 195.4 ± 30.2 174.5 ± 44.5 180.9 ± 24.8 † 186.2 ± 34.1 
(mg/dL) Interaction p = 0.019 
Triglycerides Baseline 123.2 ± 61.7 120.9 ± 61.9 110.3 ± 63.3 166.3 ± 118.5 127.3 ± 76.5 
(mg/dL) Week 10 132.6 ± 39.5 150.9 ± 71.8 118.8 ± 68.1 164.9 ± 85.2 139.8 ± 66.8 
Interaction p = 0.585 
HDL Baseline 53.7 ± 14.8 48.2 ± 14.7 53.7 ± 16.5 50.9 ± 15.2 51.7 ± 15.1 
(mg/dL) Week 10 50.5 ± 14.7 45.4 ± 13.9 52.7 ± 16.6 46.6 ± 11.8 49.0 ± 14.5 **
Interaction p = 0.635 
LDL Baseline 119.2 ± 29.7 106.5 ± 22.6 97.8 ± 33.1 112.8 ± 26.2 108.9 ± 28.9 
(mg/dL) Week 10 115.1 ± 25.4 119.8 ± 24.9 98.1 ± 36.4 101.3 ± 21.6 † 109.3 ± 28.9 
Interaction p = 0.017 
Apolipoprotein Baseline 100.5 ± 15.1 93.4 ± 19.9 84.7 ± 23.0 100.7 ± 15.2 94.4 ± 19.5 
B (mg/dL) Week 10 100.1 ± 15.5 104.4 ± 20.1 ** 88.1 ± 28.1 93.8 ± 20.2 † 96.9 ± 21.4 
Interaction p = 0.010 
TC/HDL ratio Baseline 3.9 ± 0.8 4.0 ± 1.3 3.5 ± 1.1 4.1 ±1.2 3.9 ± 1.1 
Week 10 4.0 ± 0.8 4.6 ± 1.4 3.6 ± 1.5 4.2 ± 1.4 4.1 ± 1.3 ** 
Interaction p = 0.082 
Note: ** different within group than baseline, p < 0.01; † Change (Week 10-baseline) different than HFCS 20% (p < 0.05). 
4. Discussion 
This double blind study examined changes in weight and body composition, blood lipids and blood 
pressure before and after a 10-week, free living intervention during which low fat (1%) milk was 
consumed, sweetened with either sucrose or HFCS to deliver 10% or 20% of calories from the 
sweetener in the context of mixed nutrient meals. Our main findings are: (1) when consumed as part of 
a eucaloric (weight-stable) diet for a 10-week period, fructose containing sugars do not promote 
weight gain or an atherogenic lipid profile even when consumed at two to four times the level 
currently recommended by the AHA [9]; and (2) there are no differences between sucrose and HFCS 
in these measures at typical levels of sweetener consumption. 
Sugars are ubiquitous in the food supply and have been classified as either “naturally occurring” or 
“added” [9,41,42]. Based on loss-adjusted food availability data from the U.S. Department of 
Agriculture Economic Research Service [44], the energy contribution from sugars and sweeteners 
increased by 57 cal/day between 1970 and 2008, while total calories increased 515 cal/day; it should 
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be noted that added fats and cereals/starches increased 231 and 193 cal/day, respectively [44]. The two 
leading sources of fructose in the American diet are sucrose and HFCS. Worldwide, individuals 
consume nine times as much fructose in the form of sucrose as is consumed in the form of HFCS [8]. 
In the current study, baseline sugar consumption for the cohort was slightly above population norms 
(baseline sugar consumption = 127.5 ± 82.6 g/day). Total sugar consumption increased by 
approximately 60 grams/day in both the 10% HFCS and 10% sucrose and by over 100 grams per day 
in the HFCS 20% arm and sucrose 20% arm. As already indicated, individuals followed an overall 
American Diabetes Association Exchange Diet. They were counseled to substitute the sweetened milk 
for other carbohydrate exchanges within this diet. When increases in added sugars were assessed it is 
apparent that individuals in the HFSC and sucrose 10% arm were more able to substitute the 
sweetened milk for other carbohydrates in their diets when compared with the HFCS and sucrose  
20% groups. 
While we cannot be certain that the target of 10% or 20% total energy as sucrose or HFCS was 
attained during the intervention, these increases, coupled with the high level of adherence observed on 
daily and weekly dietary checklists, suggests that the targets were largely met. 
Randomized clinical feeding trials have shown inconsistent results from testing the effects of added 
sugars on weight gain [27,28,45–49]. Differences in populations studied, study design, study 
instruments and methods may have contributed to these inconsistencies. Studies utilizing a model of 
pure fructose versus pure glucose have demonstrated differences in their effects on short term energy 
regulating hormones such as insulin, leptin and ghrelin [33–35]. It has been argued that differences in 
metabolism between fructose and glucose in the liver could contribute to increased appetite and 
calories consumed following fructose consumption thereby potentially stimulating weight gain and 
obesity [33–35]. It should be emphasized that neither fructose nor glucose is consumed in isolation to 
any appreciable degree. Studies which have compared the normally consumed sugars of HFCS and 
sucrose have not found differences in energy regulating hormones [50,51]. In the current study, no 
significant changes in body weight, body fat or waist circumference were found in any individual 
group following a 10-week, free living experiment where either 10% or 20% of calories consumed 
came from added sugars in the form of sucrose or HFCS. 
While the mean weight gain for the entire cohort of 2.2 lbs was technically within the “weight 
stable” range as defined by this study, it nonetheless bears further scrutiny since it suggests that 
individuals may have had difficulty incorporating 10% or 20% of calories from added sugars into their 
normal diets. The average weight gain of 2.2 lbs. over the 10-week study is consistent with the average 
daily increase of 384 kcals when all four groups were combined. This weight gain is also consistent 
with results other investigators have reported when adding 25% of calories as either fructose or 
glucose in free living 10 week studies [33]. 
Some evidence suggests that increased intake of added sugars may contribute to elevated blood 
pressure [10–12]. These studies include animal trials where rodents were fed extraordinary doses of 
fructose (greater than 60% of energy), acute ingestion studies where humans were fed high doses of 
different sugars (25% of energy as fructose or glucose) [33–35], and epidemiologic studies such as the 
Framingham Heart Study [52] and the Nurses Health Trial [53], where consumption of one or more 
sugar sweetened soft drink per day increased the odds of developing high blood pressure. Results of 
human studies, however, are inconsistent and very few data are available from randomized, 
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prospective trials at normal population consumed levels of added sugars. A recent meta-analysis of 
controlled feeding trials found that isocaloric substitution of fructose for other carbohydrates in 
humans did not adversely affect blood pressure [54]. 
Lipid abnormalities such as elevation of fasting plasma triglycerides have been demonstrated in 
diets high in sucrose and fructose (greater than 20% of energy) [55,56]. Fasting triglyceride elevations 
from sucrose or fructose may be more marked in men than women [18], sedentary or obese  
individuals [57], and in those with the metabolic syndrome [58]. Recent systematic reviews and  
meta-analyses, however, have reported that when fructose is substituted isocalorically for other 
carbohydrates neither fasting [59] or postprandial [60] triglycerides rise. Findings are inconsistent on 
the effects of added sugars on LDL-cholesterol levels [53–55]. 
In the current study, there was an overall decrease in HDL (p < 0.01) and increase in total 
cholesterol to HDL ratio (p < 0.01), however these measures were unaffected by treatment group 
(interaction p > 0.05). Triglycerides rose approximately 10% which was not significant. These changes 
are all consistent with a diet that replaces dietary fat with carbohydrates, particularly simple sugars. 
Diets such as the Dietary Approaches to Stop Hypertension (DASH) Diet that replace fat with 
carbohydrate from fruits, vegetables, whole grains and non-fat and low-fat dairy products that lower 
HDL cholesterol somewhat but do not increase triglycerides [17,61]. It is also possible that the failure 
to observe an increase in plasma triglycerides in the overall cohort was somewhat dependent on the 
slightly elevated baseline sugar consumption, however, as already noted, total sugar consumption rose 
appropriately in all four groups. 
The observed response in triglycerides in HFCS 20% was not a surprising observation. Increased 
intake of carbohydrates has been shown to promote formation of nascent very-low-density lipoprotein 
(VLDL) particles by combining glycerol, free fatty acids and Apo B, thus increasing plasma 
triglycerides Although our study was not designed the explore the hepatic synthesis of VLDL the 
increased Apo B observed in this group supports our speculation. 
It should also be noted that the sugars were delivered in 1% milk and as a result total protein intake 
also increased. This may have altered the food intake and also hepatic lipid metabolism. Thus, our 
reported results, related to lipid parameters must be treated with some caution. 
In the current study there were no changes in either systolic or diastolic blood pressure (p > 0.05) 
and these parameters were not affected by treatment group. These findings are different from some 
studies that have suggested that added sugars may raise blood pressure. Moreover, some epidemiologic 
studies such as the Framingham Heart Study have shown that consumption of ≥1 sugar sweetened 
carbonated soft drink per day increases the risk of developing high blood pressure [52]. Other studies 
have not demonstrated elevated blood pressure from increased sugar intake. Thus, the effects of 
intakes of simple sugars, particularly at average levels on blood pressure remain uncertain. 
A strength of the current study is that it is a double blind, randomized, prospective study with a 
relatively large sample size which explored normal population consumed levels of fructose as 
delivered through the normally consumed sweeteners, sucrose or HFCS. A further strength of this 
study is that it examined overweight and obese subjects who are more prone to the metabolic 
abnormalities assessed in the current investigation. Weaknesses of the current study include that 
subjects were only followed for 10 weeks and that children, adolescents and individuals over the age 
of 60 were excluded. 
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Further studies employing larger numbers of subjects, different population groups (e.g., adolescents 
and individuals over the age of 60) may be warranted. 
5. Conclusions 
In summary, consumption of added sugars, either from sucrose or HFCS at 10% and 20% of 
calories consumed (normal population consumption levels) in this 10 week trial, showed no significant 
changes in any group with respect to weight, adiposity, or abdominal adiposity, and no adverse effects 
on triglycerides, LDL, or blood pressure in a randomized, controlled trial of free living individuals 
lasting 10-week. These findings are consistent with other recent studies showing metabolic similarities 
between HFCS and sucrose [51,62–69]. 
Although no individual group gained significant weight, the slight weight gain when considering 
the entire cohort and the mixed response to lipid parameters, such as HDL and total cholesterol, 
warrant further trials of longer duration and larger number of subjects. 
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